{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:11:22Z","timestamp":1774005082409,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xphs.2026.104177","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:59:05Z","timestamp":1769533145000},"page":"104177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative prediction of human metabolites formed from the oxidation of the alcohol group of the glucokinase activator, TMG-123, using chimeric mice with humanized livers"],"prefix":"10.1016","volume":"115","author":[{"given":"Akiko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Sanoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2026.104177_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/dmd.121.000774","article-title":"Comparison of tissue abundance of non-cytochrome P450 drug-metabolizing enzymes by quantitative proteomics between humans and laboratory animal species","volume":"50","author":"Basit","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2026.104177_bib0002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-pharmtox-052220-105907","article-title":"Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development","volume":"62","author":"Fukami","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104177_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172252","article-title":"TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models","volume":"12","author":"Tsumura","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xphs.2026.104177_bib0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cts.13070","article-title":"Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized livers","volume":"15","author":"Yoshida","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"7-8","key":"10.1016\/j.xphs.2026.104177_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/01926233231212255","article-title":"Hepatic bile acid transporters and drug-induced hepatotoxicity","volume":"51","author":"Saran","year":"2023","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104177_bib0006","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xphs.2026.104177_bib0007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42826-019-0032-y","article-title":"Characterization and applications of chimeric mice with humanized livers for pre-clinical drug development","volume":"36","author":"Tateno","year":"2020","journal-title":"Lab Anim Res"},{"issue":"12","key":"10.1016\/j.xphs.2026.104177_bib0008","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/00498254.2016.1265160","article-title":"Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver","volume":"47","author":"Miyamoto","year":"2017","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.xphs.2026.104177_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70017","article-title":"Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration","volume":"12","author":"Shishido","year":"2024","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"10.1016\/j.xphs.2026.104177_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/toxsci\/kfm041","article-title":"Humanization of excretory pathway in chimeric mice with humanized liver","volume":"97","author":"Okumura","year":"2007","journal-title":"Toxicol Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104177_bib0011","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00498254.2015.1007112","article-title":"Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver","volume":"45","author":"Sanoh","year":"2015","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1016\/j.xphs.2026.104177_bib0012","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/bph.16270","article-title":"Quantitative prediction of CYP3A-mediated drug-drug interactions by correctly estimating fraction metabolized using human liver chimeric mice","volume":"181","author":"Miyake","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2026.104177_bib0013","unstructured":"Guidance on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2)."},{"issue":"5","key":"10.1016\/j.xphs.2026.104177_bib0014","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498254.2021.1875515","article-title":"Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes","volume":"51","author":"Uehara","year":"2021","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.xphs.2026.104177_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/dmd.114.057646","article-title":"Validation of uPA\/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS\/MS","volume":"42","author":"Ohtsuki","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2026.104177_bib0016","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/00498254.2015.1019594","article-title":"Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans","volume":"45","author":"Nakada","year":"2015","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.xphs.2026.104177_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1389200217666160125113806","article-title":"Oxidative and non-oxidative metabolomics of ethanol","volume":"17","author":"Dinis-Oliveira","year":"2016","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.xphs.2026.104177_bib0018","first-page":"7.8.1","article-title":"In vitro drug metabolism using liver microsomes","volume":"74","author":"Knights","year":"2016","journal-title":"Curr Protoc Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104177_bib0019","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1208\/s12248-020-00536-y","article-title":"The role of alcohol dehydrogenase in drug metabolism: beyond ethanol oxidation","volume":"23","author":"Di","year":"2021","journal-title":"AAPS J"},{"issue":"8","key":"10.1016\/j.xphs.2026.104177_bib0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/metabo14080429","article-title":"Electrochemical probing of human liver subcellular S9 fractions for drug metabolite synthesis","volume":"14","author":"Medina","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.xphs.2026.104177_bib0021","series-title":"Guidance for Industry: Drug Interaction Studies\u2014Study Design, Data Analysis, Implications for Dosing, and Labeling (Draft Guidance)","year":"2006"},{"issue":"2","key":"10.1016\/j.xphs.2026.104177_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1872312810666160223121836","article-title":"Efficiency in drug discovery: liver S9 fraction assay as a screen for metabolic stability","volume":"10","author":"Richardson","year":"2016","journal-title":"Drug Metab Lett."},{"issue":"2","key":"10.1016\/j.xphs.2026.104177_bib0023","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1432-1033.1993.tb18059.x","article-title":"Distribution of alcohol and sorbitol dehydrogenases. Assessment of mRNA species in mammalian tissues","volume":"215","author":"Estonius","year":"1993","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.xphs.2026.104177_bib0024","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1742-4658.2007.05665.x","article-title":"High and complementary expression patterns of alcohol and aldehyde dehydrogenases in the gastrointestinal tract: implications for Parkinson\u2019s disease","volume":"274","author":"Westerlund","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.xphs.2026.104177_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphar.2016.00260","article-title":"Alcohol and aldehyde dehydrogenases contribute to sex-related differences in clearance of zolpidem in rats","volume":"7","author":"Peer","year":"2016","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104177_bib0026","doi-asserted-by":"crossref","first-page":"59","DOI":"10.35946\/arcr.v38.1.08","article-title":"Biology, genetics, and environment: underlying factors influencing alcohol metabolism","volume":"38","author":"Wall","year":"2016","journal-title":"Alcohol Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104177_bib0027","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1265\/jjh.71.55","article-title":"[Fundamental properties of aldehyde dehydrogenase 2 (ALDH2) and the importance of the ALDH2 polymorphism]","volume":"71","author":"Matsumoto","year":"2016","journal-title":"Nihon Eiseigaku Zasshi"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:03:30Z","timestamp":1773997410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022354926000262"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104177","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative prediction of human metabolites formed from the oxidation of the alcohol group of the glucokinase activator, TMG-123, using chimeric mice with humanized livers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104177"}}